Kenneth Chow

GI fellow @unlvmedicine | Alum of @harborucla @stonybrookmed @ucla | Amateur knife sharpener | @sacramentokings loyalist | @fujifilmUS hobbyist

[Kenneth Chow @kchowk555]

Congrats to rockstar resident @sneh_sonaiya on (yet another) outstanding ACG presentation! He is applying for the GI match this year folks 👀

[Sneh Sonaiya, MD @sneh_sonaiya]

Grateful to @AmCollegeGastro for the opportunity to present our work at #ACG2026! 🙌

A big thank you to my mentors @doctornikkid @DouglasAdlerMD @HarshitKharaMD @AparnaGoelMD and my co-authors @Pran_thelife @MariaEmiliaO_ for their guidance, support, and collaboration.

[Neena S Abraham MD MACG FASGE AGAF @NeenaSAbrahamMD]

👉🏽 Treatment first line for H.pylori has evolved

👉🏽Choose:
🔸 optimized bismuth based
🔸 rifabutin triple
🔸 vonaprazam dual

👉🏽 avoid macrolides or fluoroquinolones due to resistance

👉🏽 treat X 14 days

#ACGMidwestRegional
@AmCollegeGastro

[Kenneth Chow @kchowk555]

Had an awesome time learning endoscopy from the masters and meeting the coolest fellows from across the country, Thank you @ASGEendoscopy !

[Rashmi Advani, MD, ABOM @AdvaniRashmiMD]

The #FYF first-year GI fellows course is a MUST GO for trainees wishing to learn all things endoscopy from educators across 🇺🇸 & 🇨🇦

It feels incredible to come back as faculty, teach our next generation, & learn from peers!

#GIfellow
@ChahalPrabhleen @DrEricGreenwald

[Kenneth Chow @kchowk555]

First day of #GIfellowship ✅
Orientation still isn’t over but it’s already got me pumped for the next 3 years!!

[Chris Thompson, MD @MetabolicEndo]

Grateful to @JAMANetwork
for publishing our cost-effectiveness analysis showing ESG provides greater #weightloss with cost savings compared to semaglutide for which the annual cost must be reduced 3-fold ($13,618 to $3591) to be cost-competitive. #GLP-1
https://t.co/5THzNgul3y

[Leonardo V. Riella @LVRiella]

With tremendous joy, I share that our patient who received a gene-edited pig kidney transplant was discharged home today after removal of his dialysis access. We hope that this is a first step that will bring hope to many patients waiting for a kidney transplant #xenotransplant

[Mazen Noureddin, MD, MHSc @NoureddinMD]

#Resmetirom is the first FDA drug to be approved for NASH/MASH patients without cirrhosis! #livertwitter it took long years but what a rewarding journey for those who were part of it! Happy for our patients. More work to be done @MadrigalPharma @AASLDtweets @HMethodistMD @EASLnews

[John Damianos, M.D. @john_damianosMD]

Tirzepatide is now approved for weight loss

#MedTwitter #obesity

https://t.co/HMww4PJl3x

[Kenneth Chow @kchowk555]

Had an amazing time at #ACG2023! Ran into long-lost colleagues, attended some fantastic presentations, and gave my first ACG oral presentation. Overall a successful weekend!

[UCLA Gastroenterology and Hepatology @UCLAGIHep]

Semaglutide is Effective in Achieving Weight Loss in Liver Transplant Recipients #ACG2023 #LiverTwitter

🗓️Monday, October 23
⏰2:25 pm, Plenary Session 1B-Liver

👤Dr. Kenneth Chow @kchowk555
👥Brittney Ibrahim Kabir Rahal Ryan H. Hsu Teresa Tan Katherine Meneses @sammy_saab

[Liver Transplantation Journal (LTxJournal) @LTxJournal]

#Semaglutide is effective in achieving weight loss in liver #transplant recipients by @kchowk555 et al of
@UCLAGIHEP

https://t.co/JyhZEHHtmQ

#livertwitter #livertransplant

[UCLA Gastroenterology and Hepatology @UCLAGIHep]

#NAFLD is the most common cause of liver disease 🌎Read systematic review: Comparison of Guidelines for the Screening, Diagnosis, and Noninvasive Assessment of #NAFLD 🔖 @JCEH_Hepatology

👥@kchowk555 @Pragyatf Aryan Saharan @sammy_saab #LiverTwitter
👉https://t.co/6dclF8GMTb

[UCLA Gastroenterology and Hepatology @UCLAGIHep]

This @CLD_Learning review discusses⬇️#NAFLD prevalence in #AfricanAmericans #LiverTwitter

🔑Disease severity & frequency of complications
🔑Frequency of liver transplantation for #NASH

👥UCLA: Kenneth Chow Mark Ebaid Brittney Ibrahim @sammy_saab
👉https://t.co/baywjOW0pB

[Kenneth Chow @kchowk555]

One of my favorite presentations from #TLM2022 by @serperm. A review of the history and future of the ever-evolving MELD score, featuring an excellent paper by @egnij and colleagues, definitely a must-read!

[Kenneth Chow @kchowk555]

Thank you @AASLDFoundation for this one-of-a-kind opportunity. I met so many inspiring clinicians and scientists, from the current giants in the field to the next generation of future hep fellows. I will never forget this weekend! #TLM2022 #EmergingLiverScholars

[Vivian Ortiz @VivianOrtizMD]

🎉Congratulations 🎉to the 2022 @AASLDtweets Emerging Liver Scholars #ELS22! They are so ready to get inspired by the high level of science at The Liver Meeting thanks to the support by you and the @AASLDFoundation. #TLM22 #LiverTwitter

[Kenneth Chow @kchowk555]

Hello world! I'm Kenneth, a PGY-2 at @harborucla. I was inspired by @SSharma___ at #ACG2022 to finally join #medtwitter #GItwitter #Livertwitter. I'm excited to hear about and meet other GI/hep enthusiasts out there!

Hopefully I'm using twitter right 😂